Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Kevin L Cornwell is Chairman, CEO at Utah Medical Products. OQRO lists 1 transaction filed with the SEC under this name, the latest on Oct 29, 2026, each linked to the official Form 4.
Chairman, CEO
Disclosures on record
1
Companies involved
1
1 purchase disclosed. $1,000 placed after each of the 1 purchases disclosed since 2025-11-14 would be worth $1.1K today ($1K put in); the same in the S&P 500 (SPY): $998.
Not ranked: fewer than 10 purchases measured at 90 days. The middle of the 82 ranked insiders is −5.5 pts (median, against the S&P 500).
Equal weight counts every purchase once; by size counts it for its disclosed dollars. Both are measured from the first close after it was reported. Past results describe the past, not a forecast. How this is measured · Leaderboard
Oct 29, 2026Bought~$67K
DetailsOfficial recordKevin L Cornwell bought shares on the open market in 2010, 2011 and 2026. Sales in 7 of the 18 years since 2009.
Kevin L Cornwell reported 4 open-market purchases and 71 sales since 2009; purchases in 3 different years, most recently 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | $67K1×1 trade | — |
| 2020 | — | $787K3×3 trades |
| 2019 | — | $550K4×4 trades |
| 2018 | — | $2.98M12×12 trades |
| 2016 | — | $1.25M14×14 trades |
| 2014 | — | $565K8×8 trades |
| 2013 | — | $1.62M22×22 trades |
| 2011 | $58K2×2 trades | — |
| 2010 | $46K1×1 trade | — |
| 2009 | — | $739K8×8 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
As of the latest filing on , Kevin L Cornwell reported holding 189,472 shares of Utah Medical Products (UTMD), worth about $13.6M at the last close of $72 (Nov 13, 2026), held through a see note. In the last 12 months, Kevin L Cornwell bought $67K in 1 open-market purchase.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Utah Medical Products UTMD | 189,472 | 189K see note | $72 | $13.6M | Oct 29, 2026 |
Is this Kevin L Cornwell’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated Oct 29, 2026, Kevin L Cornwell reported holding 189,472 shares of Utah Medical Products (UTMD), held indirectly. At the last close of $72 on Nov 13, 2026, that is about $13.6M. This is the stake disclosed in filings, not a net worth.
In SEC filings of the last 12 months, Kevin L Cornwell reported 1 open-market purchase worth $67K, and no open-market sale. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
Kevin L Cornwell bought shares on the open market in 2010, 2011 and 2026. Sales in 7 of the 18 years since 2009.
In SEC filings since 2009: the latest open-market purchase is from 2026; the latest open-market sale is from 2020.
Utah Medical Products (UTMD), from 2009 to 2026: 4 purchases and 71 sales.
Kevin L Cornwell reported 4 open-market purchases and 71 sales here, 2009 to 2026.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
